ORCID Profile
0000-0001-7683-2290
Current Organisations
Charles Darwin University
,
University of Technology Sydney
,
North Shore Private Hospital
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Informa UK Limited
Date: 23-07-2020
DOI: 10.1080/14647273.2020.1794062
Abstract: Understanding the likelihood of a live birth is important for fertility treatment planning, particularly when one cycle fails and further treatment may be contemplated. This study aims to estimate the chance of live birth among gestational surrogates undergoing altruistic surrogacy arrangements between 2009 and 2016 in Victoria, Australia. A total of 81 gestational surrogates with 170 embryo transfer cycles were included. Of the 170 embryo transfer cycles, the majority were single embryo transfers (SETs 97.1%), using frozen/thawed embryos (97.6%) which had been fertilized by intracytoplasmic sperm injection (77.6%). The cumulative live birth rate was 23.5% (95% CI, 15.6-33.8%) after the first cycle and increased to 50.6% (95% CI, 40.0-61.2%) after the sixth cycle. Of the 41 deliveries, 40 were singletons and one was a twin delivery. Two of the 42 deliveries were preterm, two were low birthweight and one was small for gestational age. The findings imply that surrogacy treatment can be offered up to six consecutive embryo transfer cycles to gestational surrogates. SET is encouraged in surrogacy practice to improve perinatal outcomes. These estimates can be used in counselling and decision-making for intended parents and gestational surrogates to continue a surrogacy treatment and informing public policy on assisted reproductive technology treatment.
Publisher: Phramongkutklao Hospital Foundation
Date: 24-12-2022
DOI: 10.55374/JSEAMED.V6I0.134
Abstract: Background: Surrogacy is controversial. The issue of surrogates’ exposure to legal, ethical, health and social risks has been globally debated, and most literature explores policies and regulations that could be crafted or reconsidered to protect surrogates from such hazards. However, a discussion is lacking on the need for surrogacy healthcare programs (SHPs), although surrogacy has been possible for over four decades. Objectives: This paper aimed to examine the existence (or lack) of SHPs and identify healthcare program needs to protect surrogates from risks in building surrogacy arrangements. Methods: An interdisciplinary, nonsystematic literature review and media content analysis were conducted. Medline (Ovid) and PubMed were searched for articles published between 2012 and 2022. In addition, three search engines, Google, Bing and Yahoo, were used to identify high-profile and landmark cases to supplement the literature review. Results: Seventy-eight articles were retrieved, but only 2 were reviewed. Using the 3 search engines, 53 cases were identified however, 42 were duplicates, and only 11 were analyzed. The results suggested that SHPs do not exist. High-profile and landmark cases demonstrate a need to educate prospective surrogates. Conclusion: SHPs should be compulsory for prospective surrogates to promote their well-being, and proposals for such programs should be further studied and implemented in healthcare policies.
Publisher: Informa UK Limited
Date: 07-2022
DOI: 10.1080/14647273.2020.1785643
Abstract: Multiple embryo transfer (MET) is associated with both an increased risk of multiple pregnancy and of live birth. In recent years, MET has become standard practice for most surrogacy arrangements. There is limited review of the use of MET versus single embryo transfer (SET) in surrogacy practice. The present review systematically evaluated the pregnancy outcomes of surrogacy arrangements between MET versus SET among gestational carriers. A systematic search of five computerized databases without restriction to the English language or study type was conducted to evaluate the primary outcomes: (i) clinical pregnancy (ii) live delivery and (iii) multiple delivery rates. The search returned 97 articles, five of which met the inclusion criteria. The results showed that clinical pregnancy (RR = 1.21, 95% CI: 1.06-1.39, n = 5, I
Publisher: Informa UK Limited
Date: 08-01-2021
DOI: 10.1080/14647273.2020.1870171
Abstract: Despite associated risk and public concern, commercial surrogacy remains a thriving business, and opportunities for gestational surrogates continue to exist. Surrogacy arrangements have been found to place gestational surrogates at risk, with little support or guidance to help them understand or mitigate these risk factors. This study aims to investigate the self-perception of gestational surrogates through their reflection of their own risk-related behaviours throughout the surrogacy process. Data were retrieved through interviews with fifteen Thai women who had first-hand experience of commercial surrogacy, and thematic analysis was used to interpret the data. Findings showed that the perceptions of 'trust,' 'commitment to obligation,' and 'unacceptable actions' reflected their behaviours exposing risks to detrimental behaviours, disempowerment, and isolation. Understanding these perceptions would be advantageous for health planning programmes or policies in surrogacy practice to promote women's heath as a whole.
Publisher: SAGE Publications
Date: 14-02-2022
DOI: 10.1177/00258172221074246
Abstract: This report focuses on surrogacy in Thailand which is increasingly popular with infertile and childless couples, gay couples, in iduals, and even celebrities who want children later in life. However, the debate regarding surrogacy continues. It is not widely accepted in various cases, particularly in its commercial form which is banned in many countries. However, such arrangements are still reported to be active irrespective of the ban, and in Thailand in particular. This article proposes that surrogacy legislation needs revision to enforce the current ban on commercial surrogacy.
Publisher: SAGE Publications
Date: 14-03-2021
Abstract: Transnational commercial surrogacy is a form of medical tourism undertaken by intended parents in an attempt to seek surrogates in other countries. Most intended parents are from developed countries and seek their surrogates from developing countries, predominantly from South and Southeast Asia. This arrangement led to the establishment of surrogacy businesses in South and Southeast Asia, in countries such as India and Thailand. Subsequently, the business was banned in these countries, which led to a trend of moving it to neighbouring countries where there were no regulations or restrictions. This paper maps the movement of the industry and calls for attention to re-consider or re-frame commercial surrogacy in an international framework.
Publisher: Informa UK Limited
Date: 23-06-2021
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 03-2018
No related grants have been discovered for Jutharat Attawet.